Explore evidence

93.5 %Crude ACPRs were 93.5% for SP alone in the treatment of uncomplicated P. falciparum malaria in Mali.

Malipaludismepublished 2015Malaria journaleurope_pmcdocument of 7 observations

75 %The median coverage rate for long-lasting insecticidal net (LLIN) mass distribution for the 75 health districts and the 5 epidemic years was 75.0%.

MalipaludismeHAL · Unilimdocument of 111 observations

80 %Both microscopy and qPCR diagnostic approaches detected comparable proportions (∼80%) of all RDT-positive samples infected with the dominant P. falciparum malaria parasite.

Malipaludismeobserved 2017, 2018published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 6 observationsDOI 10.4269/ajtmh.20-0593

10 %Higher proportions of non-falciparum species were detected by qPCR than microscopy: 10% against 3% infections for P. malariae.

Malipaludismeobserved 2017, 2018published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 6 observationsDOI 10.4269/ajtmh.20-0593

1.15 %P. malariae prevalence was 1.15% in active screening.

Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations

98.66 %HemotypeSC® had a negative predictive value of 98.66% to detect sickle cell disease carrier compared to high-performance liquid chromatography.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

14 %In Kilifi County, Kenya, 14% of children in the case group were girls heterozygous for G6PD c.202T.

Malidéficit en G6PDpublished 2015The Lancet. Haematologyeurope_pmcdocument of 11 observationsDOI 10.1016/s2352-3026(15)00152-0

0.82 odds_ratioG6PD c.202T heterozygous girls had significant protection from severe malaria with an odds ratio of 0.82.

Malipaludismepublished 2015The Lancet. Haematologyeurope_pmcdocument of 11 observationsDOI 10.1016/s2352-3026(15)00152-0

1 per_1000_person_weeksMalaria cases per 1,000 person-weeks peaked during the rainy season, which began in week 21 and ended in week 40.

MalipaludismeHAL · Unilimdocument of 80 observations

23.3 %The overall proportion of fever attributable to malaria parasitaemia was 23.3% during the dry season in Bandiagara district, Mali.

Malipaludismeobserved dry season of 1994published 2005Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/j.1365-3156.2005.01418.x

57 health_districts57 out of 75 health districts have been selected for Seasonal Malaria Chemoprevention (SMC) in Mali over the next 3–5 years.

Malipaludismeobserved next 3–5 yearsHAL · Unilimdocument of 95 observations

75.3 %The protective efficacy of the combination as compared with the vaccine alone was 75.3% against death from malaria.

Malipaludismepublished 2021The New England journal of medicineeurope_pmcdocument of 10 observations

96.7 %The positive predictive value of OptiMal-IT compared to thick smear microscopy was 96.7%.

Malipaludismepublished 2011Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/1475-2875-10-345

12.1 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBM was 12.1% among females.

MaliSARS-CoV-2 RBMHAL · Unilimdocument of 67 observations

598 casesThe reported number of COVID-19 cases in the Tombouctou population was 598.

MaliCOVID-19HAL · Unilimdocument of 88 observations

17.7 %Among 552 evaluable patients in the WANECAM trial, 17.7% had qPCR-detectable parasitemia at 72 hours during their first treatment episode.

Malipaludismepublished 2021Antimicrobial agents and chemotherapyeurope_pmcdocument of 2 observations

98.9 %To detect SCD carrier, SickleScan® had a negative predictive value (NPV) of 98.90% (95% CI: 98.51–99.29).

Malisickle cell disease carrierobserved 2021HAL · Unilimdocument of 103 observations

5.47 IRRParticipants living in households with more than one positive case had an incidence rate ratio of 5.47 for SARS-CoV-2 seropositivity.

MaliCOVID-19HAL · Unilimdocument of 88 observations

43.1 USDLe coût moyen par test antigénique rapide pour la COVID-19 était de 43,1 USD dans le bras intervention et de 1 449,2 USD dans le bras SOC.

MaliCOVID-19HAL · Unilimdocument of 36 observations

15,390,276 testsOver the 2018–2022 period, 76% (15,390,276) of suspected malaria cases in Mali were tested by rapid diagnostic test (RDT).

Malipaludismeobserved 2018–2022HAL · Unilimdocument of 111 observations

98.6 %Both RDTs had a negative predictive value greater than 98.6% for excluding sickle cell disease compared with HPLC.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

58.1 %The spleen rate was 58.1% among randomly selected children in the District of Yanfolila in southern Mali.

Malipaludismepublished 2000Tropical medicine & international health : TM & IHeurope_pmcdocument of 5 observations

36,046 casAu 31 janvier 2022, 36 046 cas de COVID-19 avaient été signalés au Mali.

MaliCOVID-19observed 31 janvier 2022HAL · Unilimdocument of 36 observations

5 casesDuring the study, 5 of 68 children with conditional TCD converted to abnormal TCD.

Malidrépanocytoseobserved 2008 to 2013published 2013BloodOpenAlexdocument of 10 observations

229,000,000 casEn 2019, selon les estimations de l’OMS, le nombre de cas de paludisme survenus s’élevait à 229 millions de cas détectés.

Malipaludismeobserved 2019HAL · Unilimdocument of 214 observations